Страна: Канада
Език: английски
Източник: Health Canada
TESTOSTERONE CYPIONATE
SANDOZ CANADA INCORPORATED
G03BA03
TESTOSTERONE
100MG
LIQUID
TESTOSTERONE CYPIONATE 100MG
INTRAMUSCULAR
10 ML
Schedule G (CDSA IV)
ANDROGENS
Active ingredient group (AIG) number: 0106401001; AHFS:
CANCELLED POST MARKET
2021-03-25
_ _ _TESTOSTERONE CYPIONATE INJECTION USP _ _Page 1 of 21_ PRODUCT MONOGRAPH TESTOSTERONE CYPIONATE INJECTION USP testosterone cypionate injection 100 mg/mL sterile solution USP Androgens Sandoz Canada Inc. Date of Revision: October 22, 2018 110 Rue De Lauzon Boucherville, QC, Canada J4B 1E6 Submission Control No: 212183 _ _ _TESTOSTERONE CYPIONATE INJECTION USP _ _Page 2 of 21_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................................................ 3 SUMMARY PRODUCT INFORMATION .............................................................................................................. 3 INDICATIONS AND CLINICAL USE .................................................................................................................... 3 CONTRAINDICATIONS ......................................................................................................................................... 4 WARNINGS AND PRECAUTIONS ........................................................................................................................ 4 ADVERSE REACTIONS ......................................................................................................................................... 8 DRUG INTERACTIONS ........................................................................................................................................ 10 DOSAGE AND ADMINISTRATION .................................................................................................................... 10 OVERDOSAGE ...................................................................................................................................................... 11 ACTION AND CLINICAL PHARMACOLOGY ................................................................................................... 12 STORAGE AND STABILITY ................................................................................................................................ 14 SPECI Прочетете целия документ